Pharma groups suggest changes to FDA’s guidance on replacing color additives
Regulatory NewsJoanne S. Eglovitch
ComplianceExcipientsGenericsGuidanceManufacturingPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)